Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuchong Yang

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
EMBO Reports|November 15, 2021
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to OxaliplatinXinyi Wang, Haiyang Zhang, Shengjie Yin, et al.
Disease Markers|March 1, 2016
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-AnalysisJingxu Sun, Xiaowan Chen, Peng Gao, et al.
Nature Synthesis|October 13, 2025
Synthesis of covalently linked knotted cage frameworksYuchong Yang, Tanya K Ronson, Paula C P Teeuwen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 13, 2018
Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinomaYuchong Yang, Hao Xu, Likun Zhou, et al.
BMC Cancer|June 2, 2019
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinomaYuchong Yang, Xuanzhang Huang, Likun Zhou, et al.
Angewandte Chemie (International Ed. in English)|October 16, 2025
Design and Structural Transformations of Zinc(II) Knotted Cage FrameworksYuchong Yang, Sabrina Y Hu, Tanya K Ronson, et al.
BMC Cancer|October 11, 2025
The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single centerShaohua Ge, Feixue Wang, Hongli Li, et al.
Investigational New Drugs|January 6, 2025
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancerRui Liu, Zhi Ji, Xia Wang, et al.
Therapeutic Advances in Chronic Disease|September 18, 2023
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world studyTing Deng, Jingjing Duan, Ming Bai, et al.
Journal of Gastroenterology|June 11, 2026
Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2Jingjing Duan, Yingying Jin, Yue Chen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
EMBO Reports|November 15, 2021
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to OxaliplatinXinyi Wang, Haiyang Zhang, Shengjie Yin, et al.
Disease Markers|March 1, 2016
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-AnalysisJingxu Sun, Xiaowan Chen, Peng Gao, et al.
Nature Synthesis|October 13, 2025
Synthesis of covalently linked knotted cage frameworksYuchong Yang, Tanya K Ronson, Paula C P Teeuwen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 13, 2018
Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinomaYuchong Yang, Hao Xu, Likun Zhou, et al.
BMC Cancer|June 2, 2019
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinomaYuchong Yang, Xuanzhang Huang, Likun Zhou, et al.
Angewandte Chemie (International Ed. in English)|October 16, 2025
Design and Structural Transformations of Zinc(II) Knotted Cage FrameworksYuchong Yang, Sabrina Y Hu, Tanya K Ronson, et al.
BMC Cancer|October 11, 2025
The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single centerShaohua Ge, Feixue Wang, Hongli Li, et al.
Investigational New Drugs|January 6, 2025
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancerRui Liu, Zhi Ji, Xia Wang, et al.
Therapeutic Advances in Chronic Disease|September 18, 2023
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world studyTing Deng, Jingjing Duan, Ming Bai, et al.
Journal of Gastroenterology|June 11, 2026
Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2Jingjing Duan, Yingying Jin, Yue Chen, et al.
Pageof 6